The latest filing states the doubt was alleviated.
“These factors raised substantial doubt regarding the Company's ability to continue as a going concern within one year of the date these consolidated financial statements were issued. ... Based on this forecast, management believes that the Company will have sufficient liquidity to fund its ongoing operations and anticipated working capital requirements for a period of at least twelve months after the date that these consolidated financial statements are issued. Accordingly, management has concluded that the substantial doubt about the Company's ability to continue as a going concern has been alleviated.”View the 10-K filed Sep 28, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Exascale Labs Holdings Inc. registered up to 12,350,000 Class A Common shares for resale, including 100,000 shares issuable upon warrant exercise. The company receives no proceeds from share sales but receives net proceeds from warrants exercised for cash.
Exascale Labs Holdings Inc. agreed with Sunon Inc. to sell 12 NVIDIA HGX B300 GPU servers (96 GPUs), network equipment, management servers, deployment services and 36 months of IT operation services for US$8,208,000, excluding import duties and taxes.
Exascale Labs Holdings Inc. appointed Jake Carney as Chief Financial Officer effective September 25, 2026, succeeding Gildas Bonnier’s interim role; Carney’s base salary is $6,000 per month.
Exascale Labs Holdings Inc. FY 2026 revenue was $14.8 million, up 111.3% from $7.0 million, while net loss was $12.2 million. Its Class A common stock and warrants began trading on Nasdaq on August 28, 2026.
Exascale Labs Holdings Inc. completed its Business Combination on August 27, 2026. For the year ended June 30, 2026, Exascale Labs Inc. reported revenues of $14,822,799 and a net loss of $12,162,391.
Exascale Labs Holdings Inc. reported revenue of $14.8 million for the year ended June 30, 2026, up 111.3% from $7.0 million, while gross margin improved from 15.8% to 16.3%; net loss widened to 12,162,391.
